Vista 5 VL5 SQ (Canada)

This page contains information on Vista 5 VL5 SQ for veterinary use.
The information provided typically includes the following:
  • Vista 5 VL5 SQ Indications
  • Warnings and cautions for Vista 5 VL5 SQ
  • Direction and dosage information for Vista 5 VL5 SQ

Vista 5 VL5 SQ

This treatment applies to the following species:
Manufacturer: Merck Animal Health

Cattle Vaccine

BOVINE RHINOTRACHEITIS - VIRUS DIARRHEA - PARAINFLUENZA3 - RESPIRATORY SYNCYTIAL VIRUS VACCINE, MODIFIED LIVE VIRUS - CAMPYLOBACTER FETUS - LEPTOSPIRA CANICOLA - GRIPPOTYPHOSA - HARDJO - ICTEROHAEMORRHAGIAE - POMONA BACTERIN

Product Description: The reconstituted vaccine-bacterin product contains modified-live cultures of bovine rhinotracheitis virus (IBRV), bovine virus diarrhea virus (BVD) (Types 1 & 2), parainfluenza3 virus (PI3), and bovine respiratory syncytial virus (BRSV) and inactivated cultures of Campylobacter fetus and Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona with a proprietary adjuvant.

Vista 5 VL5 SQ Indications

Vista® 5 VL5 SQ is for the vaccination of healthy cows and heifers prior to breeding as an aid in the reduction of abortion due to IBRV and as an aid in the prevention of fetal infection, including persistently infected calves caused by BVDV (Types 1 & 2). Reproductive duration of immunity (DOI) has been demonstrated to be at least 217 days for IBRV, and at least 206 days for BVDV (Types 1 & 2). In addition, it can be used as an aid in the prevention of disease caused by IBRV, BVDV (Type 2), and BRSV, as an aid in the control of disease caused by BVDV (Type 1) and PI3 virus, as an aid in reducing infertility (reproductive disease caused by Campylobacter fetus), and as an aid in preventing leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo - including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae and L. pomona) and as an aid in prevention of urinary shedding of L. hardjo organisms. Respiratory DOI has been demonstrated to be at least 182 days for IBRV, at least 206 days for BVDV (Type 1) and at least 200 days for BVDV (Type 2). Calves nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

Mixing Directions: 10 Doses - Rehydrate freeze dried vial of Vista® 5 SQ with the accompanying vial of VL5 SQ. Shake well.

50 Doses - Rehydrate freeze dried vial of Vista® 5 SQ with part of the accompanying vial of VL5 SQ diluent using the transfer needle provided (see insert for pictorial directions). Shake well. Transfer rehydrated vaccine into VL5 SQ vial using transfer needle. Remove transfer needle from VL5 SQ vial; shake well. Peel label from Vista® 5 SQ vial and place on VL5 SQ vial containing all vaccine.

Mixing Instructions

CAUTION: NEEDLE IS SHARP AND MAY CAUSE INJURY TO SELF OR ANIMALS IF NOT HANDLED PROPERLY OR DISPOSED OF PROPERLY.

Insert needle beyond breather valve into the vial of lyophilized vaccine to remove vacuum.

Turn the vial of lyophilized vaccine upside down and fully insert needle into sterile diluent or bacterin diluent bottle. Be sure to clear cap with breather valve.

Turn attached vial and bottle so the vial of lyophilized vaccine is underneath the sterile diluent or bacterin diluent bottle and squeeze enough sterile diluent or bacterin diluent into the vial of lyophilized vaccine to rehydrate the vaccine. Mix well.

Turn attached bottles so rehydrated vaccine is above sterile diluent or bacterin diluent bottle. Squeeze air into rehydrated vaccine vial.

Squeeze and release sterile diluent or bacterin diluent bottle until all the solution in the rehydrated vaccine vial drains into the sterile diluent or bacterin diluent bottle.

Separate the vial of lyophilized vaccine and needle from the sterile diluent or bacterin diluent bottle. Using the tab, remove the back of the vaccine vial label. Place the separated label over the sterile diluent or bacterin diluent bottle label to accurately identify the newly created solution.

Dosage: Inject 2.0 mL subcutaneously 14-60 days prior to breeding. Annual revaccination is recommended. A revaccination dose can be administered at more frequent intervals based upon individual farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

Cautions: Store refrigerated at 2°-7°C (35°-45°F). Do not freeze. Use entire contents immediately after rehydration. Burn the containers and all unused product. Use only in healthy cattle. Do not vaccinate within 21 days before slaughter. Do not use in pregnant cows or in calves nursing pregnant cows. If allergic reaction occurs, treat with epinephrine. Contains penicillin, streptomycin and thimerosal as preservatives.

FOR USE IN ANIMALS ONLY

Intervet Inc., Omaha, NE 68103, USA

1 888 306-0069 (Canada)

U.S. Vet Lic. No. 165A

10 Doses

20 mL

11-0081PFC

90491001-C

50 Doses

100 mL

11-0082PFC

90495001-C

NAC No.: 12082043

MERCK ANIMAL HEALTH
Intervet Canada Corp.

16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
Order Desk:   514-428-7013
Toll-Free:   866-683-7838
Fax:   Toll-free 888-498-4444; local 514-428-7014
Website:   www.merck-animal-health.ca
Every effort has been made to ensure the accuracy of the Vista 5 VL5 SQ information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-05-28

(web3)